← FDA DRUG APPROVALS

FDA ANDA · ANDA090633

CALCIPOTRIENE

Sponsor: GLENMARK PHARMS

APPLICATION
ANDA090633
TYPE
ANDA
ORIGINAL APPROVAL
2010-03-24
LATEST ACTION
2019-05-24
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription

Products

CALCIPOTRIENEPrescription
CALCIPOTRIENE 0.005% · OINTMENT · TOPICAL

Approval history

2019-05-24Labeling · Supplement 5 · standardAP
2019-05-24Labeling · Supplement 6 · standardAP
2015-08-13Manufacturing (CMC) · Supplement 1AP
2010-03-24OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →